Johnson & Johnson (JNJ) Hip Implant Verdict to be Readt at 12:30pm ET
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
California Jury Says J&J (JNJ) Defectively Designed ASR Hip Device
March 8, 2013 12:46 PM ESTJohnson & Johnson (NYSE: JNJ) defectively designed ASR hip device, California jury says. The company recalled 93,000 ASR hips in August 2010 after failures.
This was the first trial of 10,750 lawsuits filed over the ASR hip device.
UPDATE - J&J will pay $8.3 million in damages.
Shares of J&J are up 0.4 percent.... More
